Mountain View, CA, United States of America

Yafei Hou

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Hangzhou Converd Co., Ltd., Hangzhou Convero Co., Ltd., Other. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yafei Hou. Retrieved from https://idiyas.com/inventor/yafei-hou-6e95mhpz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Yafei Hou and His Contributions to Tumor Treatment

Introduction

Yafei Hou, a prominent inventor based in Mountain View, CA, has made significant strides in the field of therapeutic agents for cancer treatment. With two patents to his name, his work focuses on utilizing nucleic acids and modified immune cells to develop innovative solutions for combating tumors.

Latest Patents

Yafei Hou's latest patents include two noteworthy inventions geared towards enhancing anti-tumor responses. The first patent, titled "Therapeutic agents comprising nucleic acids and TCR modified immune cells and uses thereof," details a therapeutic agent consisting of a nucleic acid and T cell receptor (TCR) modified immune cell. This agent features a composition that includes a nucleic acid designed to introduce a labeling polypeptide coding sequence into cancer cells, which can be presented on their surface by MHC class I molecules. This innovation aims to achieve a synergistic treatment effect and offers a promising new pathway for tumor treatment.

The second patent, "Therapeutic compositions and applications that comprise nucleic acids and adoptively transferred immune cell," outlines a method for administering a therapeutic agent for treating tumors or cancers. This agent combines two pharmaceutical compositions: one contains a nucleic acid designed to prompt tumor cells to express specific antigenic epitope peptides, and the other includes immune cells cultivated from blood or tumor tissue. This combination aims to elicit a robust immune response against tumor cells in the subject.

Career Highlights

Yafei Hou's career reflects his dedication to advancing cancer therapies through innovative scientific approaches. His work has led to significant developments in the field of immunotherapy, emphasizing the potential of harnessing the body's immune system to fight cancer more effectively.

Collaborations

Throughout his career, Hou has collaborated with esteemed professionals, including Fang Hu and Jipo Sheng. These partnerships have played a crucial role in the development and refinement of his innovative therapeutic agents, enhancing the collective efforts to combat cancer through cutting-edge research.

Conclusion

Yafei Hou stands out as a visionary inventor whose contributions to the field of cancer treatment are noteworthy. His patents reflect a commitment to creating advanced therapeutic agents that leverage the power of nucleic acids and immune cells to provide new hope in the fight against tumors. As the landscape of cancer treatment continues to evolve, Hou's innovations pave the way for future breakthroughs in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…